Summary
Kent Lake urged Quanterix shareholders to vote against the merger with Akoya, arguing it is a bailout that unfairly values Quanterix at a negative enterprise value while rewarding a weaker, cash-burning Akoya. The deal would slash Quanterix’s net cash per share by nearly 60%, shorten its cash runway, and distract from its high-value Alzheimer’s diagnostics program. Governance conflicts, a flawed process, and a 55% stock price drop since announcement further underscore that Quanterix is stronger and more valuable as a standalone company.
Company Name: Quanterix Corp
Symbol: QTRX
Filing Date: Apr-21-2025
Filer Name: Kent Lake PR LLC
Source:
https://www.sec.gov/Archives/edgar/data/1503274/000153949725001180/exh1.pdf
Members Only · Snowball Research
Continue reading this report
Unlock the full analysis, investor activity breakdown, and complete commentary.
Try first
Free Trial
Submit a request with your professional email address and we'll send you a sample report.
Request Free Trial
Most popular
Subscribe
Full access to all reports, weekly digests, and the archive.
Subscribe Now
The best research idea generation service you've never heard of.
Edwin Dorsey · The Bear Cave · 2024 Hedge Fund Analyst Christmas List
Fresh, unbiased data which allows independent consumers to formulate their own opinion. Unique, stellar and a bargain.
J. Carlo Cannell · Cannell Capital LLC
Raghu's research saves us an enormous amount of time. Our payback on subscribing is enormous.
David Nierenberg · The D3 Family Funds